Synergy Pharmaceuticals Engages The Trout Group for Investor Relations Services
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced that it has engaged The Trout Group LLC a leading investor relations and strategic advisory firm.